132 related articles for article (PubMed ID: 8138014)
21. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
Kang YJ; Enger MD
Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
[TBL] [Abstract][Full Text] [Related]
22. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
Mayer RD; Maines MD
Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
[TBL] [Abstract][Full Text] [Related]
23. Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetate-induced lipid peroxidation in rats and mice.
Preece NE; Evans PF; King LJ; Parke DV
Xenobiotica; 1990 Sep; 20(9):879-86. PubMed ID: 2238709
[TBL] [Abstract][Full Text] [Related]
24. Effect of N-acetyl-cysteine, D-penicillamine and buthionine sulfoximine on glutathione levels and CNS oxygen toxicity in rats.
Lalitha T; Kerem D; Yannai S
Pharmacol Toxicol; 1990 Jan; 66(1):56-61. PubMed ID: 2308909
[TBL] [Abstract][Full Text] [Related]
25. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
VanSteenhouse JL; Fettman MJ; Gould DH
Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
[TBL] [Abstract][Full Text] [Related]
26. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
27. Vitamin E prevents buthionine sulfoximine-induced biochemical disorders in the rat.
Rajasekaran NS; Devaraj NS; Devaraj H
J Pharm Pharmacol; 2004 Jan; 56(1):91-9. PubMed ID: 14983899
[TBL] [Abstract][Full Text] [Related]
28. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
29. Increased lipid peroxidation in the liver and kidney and their mitochondrial fractions following buthionine sulfoximine induced glutathione depletion in guinea pigs.
Seçkin S; Doğru-Abbasoğlu S; Başaran-Küçükgergin C; Yavu E; Cevikbaş U; Aykaç-Toker G; Uysal M
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):299-308. PubMed ID: 12889513
[TBL] [Abstract][Full Text] [Related]
30. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
Ishikawa M; Takayanagi G; Sasaki K
Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats.
Wu DF; Griffith OW; Reidenberg MM
Pharmacology; 1990; 40(5):250-7. PubMed ID: 2274571
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
33. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
Coursin DB; Cihla HP
Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
[TBL] [Abstract][Full Text] [Related]
34. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Nakahori Y; Yamamoto K
Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
[TBL] [Abstract][Full Text] [Related]
35. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
36. Hepatocytes in primary culture become susceptible to paracetamol injury after depletion of glutathione using DL-buthionine-SR-sulphoximine (BSO).
Hue DP; Griffith KL; McLean AE
Biochem Pharmacol; 1985 Dec; 34(24):4341-4. PubMed ID: 4074395
[No Abstract] [Full Text] [Related]
37. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
Campbell EB; Hayward ML; Griffith OW
Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
[TBL] [Abstract][Full Text] [Related]
38. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
Maitra I; Serbinova E; Tritschler HJ; Packer L
Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
[TBL] [Abstract][Full Text] [Related]
39. Transport into brain of buthionine sulfoximine, an inhibitor of glutathione synthesis, is facilitated by esterification and administration of dimethylsulfoxide.
Steinherz R; Mårtensson J; Wellner D; Meister A
Brain Res; 1990 Jun; 518(1-2):115-9. PubMed ID: 2390716
[TBL] [Abstract][Full Text] [Related]
40. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Ravindranath V; Boyd MR
Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
